Re:High genetic barrier to SARS-CoV-2 polyclonal neutralizin...
by walterbell on Monday September 20, 2021 @06:00PM
(#28599572)
You would want the exposure to be nasal, so that would require a distribution system for inhalers containing the alpha variant.
From the date of the first vaccine, until 2 weeks after the second vaccine, the immune system goes through many changes enroute to gaining protection from serious illness. It is recommended to avoid immune system stress, exposure to any pathogens (e.g. visiting hospitals), physical exertion, etc. during the 2 week period immediately after the first vaccine. If one is infected with anything earlier than 2 weeks after the 2nd vaccine, it will be recorded as an unvaccinated infection.
Anyone (vaccinated, partially vaccinated or unvaccinated) who gets infected should immediately avail themselves of early treatment options, e.g. monoclonal antibodies (free and available in some states), upcoming antiviral tablets from Pfizer and Merck (in trials) or other therapeutics on the global market. Early treatment speeds recovery. Without early treatment, the graph of outcomes becomes complex.
From the date of the first vaccine, until 2 weeks after the second vaccine, the immune system goes through many changes enroute to gaining protection from serious illness. It is recommended to avoid immune system stress, exposure to any pathogens (e.g. visiting hospitals), physical exertion, etc. during the 2 week period immediately after the first vaccine. If one is infected with anything earlier than 2 weeks after the 2nd vaccine, it will be recorded as an unvaccinated infection.
Anyone (vaccinated, partially vaccinated or unvaccinated) who gets infected should immediately avail themselves of early treatment options, e.g. monoclonal antibodies (free and available in some states), upcoming antiviral tablets from Pfizer and Merck (in trials) or other therapeutics on the global market. Early treatment speeds recovery. Without early treatment, the graph of outcomes becomes complex.